🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

77 notícias encontradas para "drugs"
Scientists finally crack nature's secret for building better cancer drugs
Scientists finally crack nature's secret for building better cancer drugs
Researchers have cracked the code behind bacteria's ability to naturally manufacture multiple versions of powerful anti-cancer drugs. The discovery could make it much easier to engineer new cancer treatments inspired by nature, including improved versions of existing medicines.
New neutron method reveals inner architecture of drug delivery particles
Modern medicine increasingly relies on targeted drug delivery—a process during which tiny particles (nanoparticles) transport drugs to specific parts of the body. To ensure these treatments are safe and effective, scientists need to understand exactly how these nanoparticles are
Popular weight-loss drugs Ozempic and Wegovy may slow biological aging
Popular weight-loss drugs Ozempic and Wegovy may slow biological aging
Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults with HIV, marking the first clinical evidence that the drug may influence human aging. Although the findings are encouraging, scientists say larger studies a
Foto: Gustavo Fring / Pexels
Dicas
‘A new consumer’: how weight-loss drugs are shaking up clothes shopping
As they slim down, UK and US users of GLP-1 jabs and pills are changing their spending habits – and their wardrobesTell us: what does the new weight-loss pill mean for you?“I’m now at a point where I’m going to buy even more clothes,” says Hayley Grice, 50, from Shropshire, who has dropped seven sizes after starting on the GLP-1 weight loss jab Mounjaro two years ago. “I’m very happy with my physique right now.”Grice, the financial director of a business she set up with her husband, tr
Foto: Mitchell Henderson / Pexels
Dicas
UK housing market downturn eases but sentiment remains ‘fragile’, surveyors say – business live
Brent crude dips slightly below $78 a barrel; most Asian stock markets bounce backBritain’s second-biggest drugmaker GSK has also taken a hit from recent drug failures.The Californian biotech Alector has said that GSK has ended their neuroscience collaboration covering ​two experimental antibody drugs, after both drug candidates suffered setbacks in clinical trials.The CARDIO-TTRansform trial was designed to examine the role of Wainua, a gene silencer treatment, on top of today’s stand